The synthetic biology company AbSci said today that it is acquiring Totient, a discovery firm using human immune supporters to uncover new antibodies and their…
The synthetic biology company AbSci said today that it is acquiring Totient, a discovery firm using human immune supporters to uncover new antibodies and their…